Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 70.35
-1.60 (-2.22%)
Feb 13, 2026, 4:08 PM HKT
Shanghai Henlius Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 824.3 | 820.47 | 546.02 | -695.26 | -984.05 | -993.54 |
Depreciation & Amortization | 415.22 | 367.24 | 353.32 | 273.12 | 196.56 | 133.43 |
Other Amortization | 7.56 | 7.56 | 5.91 | 4.48 | 32.62 | 5.79 |
Loss (Gain) From Sale of Assets | -0.61 | -0.82 | -0.72 | 0.25 | 0.93 | -0.81 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.01 |
Stock-Based Compensation | - | - | 2.59 | 12.52 | 48.42 | 35.73 |
Provision & Write-off of Bad Debts | -1.94 | -5.03 | 9.03 | 1.64 | 0.17 | - |
Other Operating Activities | 98.13 | 109.11 | 152.88 | 284.19 | 284.61 | 94.17 |
Change in Accounts Receivable | -399.92 | -165.95 | -283.77 | -161.41 | -99.7 | -340.94 |
Change in Inventory | -56.15 | 23.86 | -22.34 | -340.64 | -91.71 | -53.73 |
Change in Accounts Payable | 248.07 | 161.37 | -108.34 | 312.56 | 20.04 | 145.76 |
Change in Unearned Revenue | 971.31 | 120.24 | 495.12 | 227.14 | 303.83 | 217.6 |
Change in Other Net Operating Assets | -344.48 | -196.15 | -101.78 | 1,063 | 378.68 | 146.97 |
Operating Cash Flow | 1,761 | 1,242 | 1,048 | 981.62 | 90.39 | -609.58 |
Operating Cash Flow Growth | 82.21% | 18.51% | 6.75% | 985.96% | - | - |
Capital Expenditures | -233.65 | -164.01 | -473.67 | -584.97 | -460.43 | -557 |
Sale of Property, Plant & Equipment | 0.25 | 0.24 | 0.02 | 6.56 | 0.55 | 0.27 |
Cash Acquisitions | - | - | -15 | - | - | - |
Sale (Purchase) of Intangibles | -774.74 | -673.2 | -537.77 | -780.32 | -670.76 | -955.52 |
Investment in Securities | 142.17 | -73 | -120 | - | - | - |
Other Investing Activities | - | - | 141.98 | - | -550.61 | - |
Investing Cash Flow | -865.97 | -909.97 | -1,004 | -1,359 | -1,681 | -1,512 |
Long-Term Debt Issued | - | 2,674 | 2,512 | 2,859 | 2,096 | 1,443 |
Total Debt Issued | 2,518 | 2,674 | 2,512 | 2,859 | 2,096 | 1,443 |
Long-Term Debt Repaid | - | -3,184 | -2,237 | -1,886 | -1,364 | -392.54 |
Total Debt Repaid | -2,962 | -3,184 | -2,237 | -1,886 | -1,364 | -392.54 |
Net Debt Issued (Repaid) | -443.45 | -510.34 | 274.34 | 972.77 | 731.67 | 1,050 |
Other Financing Activities | -118.03 | -133.03 | -129.91 | -114.75 | -83.36 | -54.66 |
Financing Cash Flow | -561.48 | -643.37 | 144.43 | 858.02 | 648.3 | 995.79 |
Foreign Exchange Rate Adjustments | 12.57 | 15.18 | 6.27 | 37.59 | -16.77 | -60.75 |
Net Cash Flow | 346.61 | -296.26 | 194.19 | 518.49 | -959.33 | -1,187 |
Free Cash Flow | 1,528 | 1,078 | 574.25 | 396.65 | -370.04 | -1,167 |
Free Cash Flow Growth | 142.80% | 87.70% | 44.77% | - | - | - |
Free Cash Flow Margin | 26.35% | 18.83% | 10.64% | 12.34% | -21.99% | -198.54% |
Free Cash Flow Per Share | 2.81 | 1.98 | 1.06 | 0.73 | -0.69 | -2.20 |
Cash Interest Paid | 118.03 | 133.03 | 129.91 | 114.75 | 83.2 | 28.34 |
Cash Income Tax Paid | 22.45 | 28.26 | 20.71 | 1.37 | - | - |
Levered Free Cash Flow | -562.01 | 176.66 | -709.99 | -1,019 | -857.51 | -2,271 |
Unlevered Free Cash Flow | -490.49 | 253.46 | -640.9 | -952.46 | -804.5 | -2,243 |
Change in Working Capital | 418.83 | -56.64 | -21.11 | 1,101 | 511.13 | 115.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.